519 672 2121
Close mobile menu
Published on: 1 Nov 2023 By ,

Class Action pursued for Canadians alleging harms from Ozempic, semaglutide drugs

Ozempic, the popular drug approved in Canada to treat diabetes, has been linked to serious harms to users. Studies have shown a link between the use of semaglutide – the active ingredient in Ozempic – and an increased risk of severe gallbladder-related harms, including gallstones, and gastro…

View the post titled Class Action pursued for Canadians alleging harms from Ozempic, semaglutide drugs